Literature DB >> 2884467

Ciprofloxacin for cholangitis after hepatic portoenterostomy.

R H Houwen, C M Bijleveld, H G de Vries-Hospers.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1987        PMID： 2884467     DOI： 10.1016/s0140-6736(87)90663-5

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  10 in total

1.  Successful treatment of recurrent cholangitis with antibiotic maintenance therapy.

Authors:  S J van den Hazel; P Speelman; G N Tytgat; D J van Leeuwen
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1994-08       Impact factor: 3.267

Review 2.  Biliary tract infections: a guide to drug treatment.

Authors:  J F Westphal; J M Brogard
Journal:  Drugs       Date:  1999-01       Impact factor: 9.546

3.  Prognosis of extrahepatic biliary atresia.

Authors:  R H Houwen; R P Zwierstra; R S Severijnen; J Bouquet; G Madern; A Vos; N M Bax; H S Heymans; C M Bijleveld
Journal:  Arch Dis Child       Date:  1989-02       Impact factor: 3.791

Review 4.  Use of quinolones in pediatrics.

Authors:  U B Schaad
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1991-04       Impact factor: 3.267

Review 5.  Treatment of intra-abdominal infections with quinolones.

Authors:  J A Smith
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1991-04       Impact factor: 3.267

Review 6.  Ciprofloxacin. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use.

Authors:  D M Campoli-Richards; J P Monk; A Price; P Benfield; P A Todd; A Ward
Journal:  Drugs       Date:  1988-04       Impact factor: 9.546

Review 7.  Safety of ciprofloxacin in children: worldwide clinical experience based on compassionate use. Emphasis on joint evaluation.

Authors:  V Chyský; K Kapila; R Hullmann; G Arcieri; P Schacht; R Echols
Journal:  Infection       Date:  1991 Jul-Aug       Impact factor: 3.553

Review 8.  Quinolones and the gastrointestinal tract.

Authors:  B E Murray
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1989-12       Impact factor: 3.267

9.  Pharmacokinetics of single-dose oral ciprofloxacin in infants and small children.

Authors:  H Peltola; M Väärälä; O V Renkonen; P J Neuvonen
Journal:  Antimicrob Agents Chemother       Date:  1992-05       Impact factor: 5.191

Review 10.  Safety and efficacy of ciprofloxacin in paediatric patients--review.

Authors:  R Kubin
Journal:  Infection       Date:  1993 Nov-Dec       Impact factor: 3.553
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.